Alt tag

Adviser’s Picks 2021

Boosting confidence in preventing recurrent thrombotic events in patients with peripheral artery disease following revascularization

Boosting confidence in preventing recurrent thrombotic events in patients with peripheral artery disease following revascularization

Boosting confidence in preventing recurrent thrombotic events in patients with peripheral artery disease following revascularization

When should dual pathway inhibition be stopped in patients with symptomatic PAD following peripheral revascularization?

When should dual pathway inhibition be stopped in patients with symptomatic PAD following peripheral revascularization?

When should dual pathway inhibition be stopped in patients with symptomatic PAD following peripheral revascularization?

Antithrombotic protection after lower-extremity revascularization: Can clopidogrel be used alongside DPI?

Antithrombotic protection after lower-extremity revascularization: Can clopidogrel be used alongside DPI?

Antithrombotic protection after lower-extremity revascularization: Can clopidogrel be used alongside DPI?

Join more than 1.500 of your peers to stay up to date with the latest in thrombosis.

Sign up now!